Eric Alspaugh
FOUNDER
Eric's Bio
Growing up in San Diego, he always had a love for science. Eric started his career as a bench scientist after graduating from the UCSD with a degree in Biology. While working at Immusol (now ItherX) in San Diego, Eric had an opportunity to be involved in research for HIV, functional genomics, a class of catalytic RNAs called ribozymes for therapeutic treatment of cardiovascular, ophthalmic and dermal indications. He was involved in the development of pre-clinical pharmaceuticals and obtained regulatory clearances. During that time, he was also focused on research, development, and pre-clinical studies on three separate INDs.
In 2004, he graduated from law school at the University of San Diego, and was admitted to practice with the USPTO, and the California Bar. After law school, Eric joined Haight Brown & Bonesteel where he focused on intellectual property, environmental law, and business transactions. He was recruited to serve as patent counsel for Biosensors International, a global medical device firm. Eric helped Biosensors International valuation increase from $700MM to over $4B while listed on the Singapore Stock Exchange. Additionally, Eric managed Biosensors International’s international patent litigation at the Hague successfully with the Court finding non-infringement of the asserted patent.
Eric left Biosensors International to co-found Advanced Bifurcations Systems and Sterling Vascular. Advanced Bifurcation Systems continues to develop its patented drug eluting stent and novel catheter platform in joint venture with Cedars Sinai and a publicly traded US medical device manufacturer. Eric served as counsel for several international based technology companies and an Orange County technology incubator. He has been fortunate to participate in numerous mergers and acquisitions with his companies and now participates selectively with investment banks, private equity, and a couple of family offices performing IP portfolio valuation, due diligence, and corporate compliance functions.
Eric was a founding member and serves as Counsel for DeviceAlliance. He spent time as an instructor at UCI Extension teaching various regulatory coursework and designed and taught his own course, Biomedical Business and Legal Management Essentials. He serves as a Judge Advocate General (JAG) Officer in the California State Guard Legal Support Command. He has been a guest speaker at Blackstone UCI Launchpad, and lectured at numerous Orange County incubators, and the Hong Kong Business Association.
As a licensed California real estate broker for over 15 years, Eric has a diverse background in advising clients on complex business transactions involving commercial real estate, lease backs, 1031 exchanges, and commercial development. The interplay between tax, real estate, and intellectual property transactions is complex and Eric enjoys advising clients proactively so that the client can truly make informed business decisions.
Eric has volunteered thousands of hours for numerous non-profits advocating for community organizations, animal rights, and underserved communities. Eric previously volunteered at the Orange County Bar Association as a Mandatory Fee Arbitrator. He is currently providing pro bono services to service members through his JAG command.
Eric and his wife, Virginia reside in Dana Point, CA. In his free time, he enjoys cooking, woodworking, biking and watching his four children’s baseball games and dance recitals.
Alspaugh Law has been a life-saver with our patents and trademarks. Their advice and knowledge has helped us to navigate the rocky mud that is the USPTO. We consider Alspaugh Law a valued member of our team and look forward to their help growing our company as a whole.
Theodor F. Gillebaard President (EZ Pool Products, Inc.)
Alspaugh Law did a great job helping me incorporate and build my business. They negotiated my contracts, commercial lease, and sale of my company without any headaches. Their professionalism and commitment to providing effective solutions made the process of starting a company very comfortable for me.
Sandeep Lad Owner (Caring Pharmacy, Inc.)
I appreciate Virginia's sense of timely follow-up and genuine responses which provide a level of comfort and trust that her advice also considers our best interests for long-term strategic planning.
Jake Van Namen President (Prosolve Advisory, Inc.)
Alspaugh Law has provided legal services to me related to intellectual property, contracts, and corporate governance. The are responsive, diligent, knowledgeable, fast, easy to communicate with, and overall very effective. On one particular occasion I contacted them with an urgent situation on a holiday. They quickly took up the case and resolved the matter. I highly recommend Alspaugh Law.
Ron Cohen President (Evyrx, Inc.)
Eric did a great job advising Sterling Vascular on intellectual property and general corporate matters. I highly recommend Eric for all your legal needs.
Robert Ndondo-Lay President (Sterling Vascular Systems, Inc.)
Alspaugh Law has done a great job advising me on all our business needs. Their expert advice saved me time and money on real estate and insurance.
Robert Hackett Managing Member (Luthor LLC)
Publications:
Quality Issues with Contract Manufactured Chimeric Ribozyme, Joan Robbins, Eric Alspaugh, Ritchard Tritz, Lisa Krause, Jack Barber. Immusol Inc. San Diego, CA Abstract presented at Oligonucleotide Synthesis conference, San Franciso, CA June 24th-25th, 1998
Local Delivery of Ribozymes Targeting PCNA Before or After Stenting Inhibits In-Stent Stenosis in a Porcine Model, Martin Sebatian, Hidehiko Honda, Joan Robbins, Eric Alspaugh, Neal Eigler, Raj Makkar, Frank Litvak. Cedars-Sinai Medical Center, Los Angeles, CA published The American Journal of Cardiology, September 22, 1999
Non-Viral Vectors for the Treatment of Disease, Eric Alspaugh, Douglas Antelamar, Jack Barber, Karl Csaky, Bingliang Fang, Peter Frederick, Hidehiko Honda, Duane Johnson, Frank Litvak, Todd Machemer, Rajagopal Ramesh, Joan Robbins, Jack Roth, Martin Sebastian, Richard Tritz, Shu Fen Wen, Zheng Wu, and Nancy Smythe-Templeton. Immusol Inc. San Diego, CA published abstract, American Society Gene Therapy, September 1999
Chimeric Ribozyme to Proliferating Cell Nuclear Antigen Prevents Retinal Detachment in a Model of Proliferative Vitreoretinopathy, N. Madava, P. Blackburn, M.W. Wilson, D.B. Paul, E.B. Alspaugh, C. Whiting, J.R. Barber, J.M. Robbins, B.M. Broswick, C.A. Kruse.Immusol Inc. San Diego, CA published abstract Investigative Ophthalmology & Visual Science, March 15, 2000
Ribozyme to Proliferating Cell Nuclear Antigen to Treat Proliferative Vitreoretinopathy, Mandava, N., Blackburn, P., Paul, D.B., Wilson, M.W., Read, S.B., Alspaugh, E., Tritz, R., Barber, J.R., Robbins, J.M., Kruse, Carol A., Investigative Ophthalmology & Visual Science, October 2002, Vol. 43, No. 10.
Safety Evaluation of Proliferating Cell Nuclear Antigen Targeted Ribozyme to Inhibit Cell Proliferation in Proliferative Vitreoretinopathy, Habita, C., Gutenberg, P., Alspaugh, E., Houston, B., Zeroula, C., Barber, J., Preclinica, March/April 2003, Vol. 1, No. 1.
Local Delivery of Anti-PCNA Ribozymes Before or After Stenting Using a Microporous Catheter Inhibits Neointimal Hyperplasia in a Porcine Model, Martin Sebatian MBBS FRACP, Hidehiko Honda MD, Joan Robbins PhD, Eric Alspaugh BS, Richard Tritz PhD, Ben Keily BS, Jack Barber PhD, Raj Makkar MD, Neal Eigler MD FACC, Frack Litvak MD FACC. Cedars-Sinai Medical Center, Los Angeles, CA in Press
Chimeric Ribozyme to Proliferating Cell Nuclear Antigen (PCNA) Prevents Retinal Detachment in a Model of Proliferative Vitreoretinopathy, Naresh Mandava1, Peter Blackburn1, Matthew W. Wilson4, David B. Paul2, Susana B. Reed2, Eric Alspaugh5, Richard Tritz5, Jack Barber5, Joan M. Robbins5, Carol A. Kruse2,3. Departments of Ophthalmology1, Immunology2, and Pathology3, University of Colorado Health Sci Ctr, Denver, CO, Department of Ophthalmology, University of Tennessee4, Memphis, TN and Immusol, Inc.5, San Diego, CA submitted
Some of our Partners and Affiliations:
Investments in startups and business are our speciality
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Investments in startups and business are our speciality
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Investments in startups and business are our speciality
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Investments in startups and business are our speciality
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.